Literature DB >> 11287097

Increased insulin concentrations and glucose storage in neuropeptide Y Y1 receptor-deficient mice.

R Burcelin1, H Brunner, J Seydoux, B Thorensa, T Pedrazzini.   

Abstract

Mice lacking NPY Y1 receptors develop obesity without hyperphagia indicating increased energy storage and/or decreased energy expenditure. Then, we investigated glucose utilization in these animals at the onset of obesity. Fasted NPY Y1 knockouts showed hyperinsulinemia associated with increased whole body and adipose tissue glucose utilization and glycogen synthesis but normal glycolysis. Since leptin modulates NPY actions, we studied whether the lack of NPY Y1 receptor affected leptin-mediated regulation of glucose metabolism. Leptin infusion normalized hyperinsulinemia and glucose turnover. These results suggest a possible mechanism for the development of obesity without hyperphagia via dysfunction in regulatory loops involving NPY, leptin and insulin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11287097     DOI: 10.1016/s0196-9781(01)00357-6

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  11 in total

Review 1.  Osteoblastic Actions of the Neuropeptide Y System to Regulate Bone and Energy Homeostasis.

Authors:  Harry Horsnell; Paul A Baldock
Journal:  Curr Osteoporos Rep       Date:  2016-02       Impact factor: 5.096

2.  Comparison between cafeteria and high-fat diets in the induction of metabolic dysfunction in mice.

Authors:  Talita S Higa; Acauã V Spinola; Miriam H Fonseca-Alaniz; Fabiana Sant Anna Evangelista
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2014-03-13

Review 3.  Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.

Authors:  Robert E Steinert; Christine Feinle-Bisset; Lori Asarian; Michael Horowitz; Christoph Beglinger; Nori Geary
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

4.  In vivo and in vitro degradation of peptide YY3-36 to inactive peptide YY3-34 in humans.

Authors:  Signe Toräng; Kirstine Nyvold Bojsen-Møller; Maria Saur Svane; Bolette Hartmann; Mette Marie Rosenkilde; Sten Madsbad; Jens Juul Holst
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-01-27       Impact factor: 3.619

5.  Bone-specific overexpression of NPY modulates osteogenesis.

Authors:  I Matic; B G Matthews; T Kizivat; J C Igwe; I Marijanovic; S T Ruohonen; E Savontaus; D J Adams; I Kalajzic
Journal:  J Musculoskelet Neuronal Interact       Date:  2012-12       Impact factor: 2.041

6.  Satiety, but not total PYY, Is increased with continuous and intermittent exercise.

Authors:  M E Holmstrup; T J Fairchild; S Keslacy; R S Weinstock; J A Kanaley
Journal:  Obesity (Silver Spring)       Date:  2013-05-25       Impact factor: 5.002

Review 7.  Hypothalamus-adipose tissue crosstalk: neuropeptide Y and the regulation of energy metabolism.

Authors:  Wei Zhang; Mark A Cline; Elizabeth R Gilbert
Journal:  Nutr Metab (Lond)       Date:  2014-06-10       Impact factor: 4.169

8.  Peripheral activation of the Y2-receptor promotes secretion of GLP-1 and improves glucose tolerance.

Authors:  Keval Chandarana; Cigdem Gelegen; Elaine E Irvine; Agharul I Choudhury; Chloé Amouyal; Fabrizio Andreelli; Dominic J Withers; Rachel L Batterham
Journal:  Mol Metab       Date:  2013-03-14       Impact factor: 7.422

9.  Sitagliptin and Roux-en-Y gastric bypass modulate insulin secretion via regulation of intra-islet PYY.

Authors:  Claudia Guida; Laura J McCulloch; Mahdieh Godazgar; Sam D Stephen; Charlotte Baker; Davide Basco; Jiawen Dong; Duan Chen; Anne Clark; Reshma D Ramracheya
Journal:  Diabetes Obes Metab       Date:  2017-10-10       Impact factor: 6.577

Review 10.  Peptide YY: more than just an appetite regulator.

Authors:  Shanta J Persaud; Gavin A Bewick
Journal:  Diabetologia       Date:  2014-06-11       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.